⚠
✓
Sienna Cancer Diagnostics Ltd
Sienna Cancer Diagnostics Ltd
Sector: Healthcare
Description
Sienna Cancer Diagnostics Ltd (ASX: SDX), established in 2002, is a medical technology company that is based out of Australia and operating across Australia, the United States, and Europe. The services include biotechnology and pharmaceutical R&D, commercialisation, manufacturing operation, and other allied services for clinical diagnostic laboratories. The company specifically operates through its platform that is based on the technology for detecting biomarker telomerase, which is present in almost all kind of epithelial cancers.Peers
ANP
Antisense Therapeutics Ltd.
PTX
Prescient Therapeutics Limited
CYP
Cynata Therapeutics Limited
NOX
Noxopharm Limited
MRNA
Moderna Inc
CHM
Chimeric Therapeutics Limited
NVAX
Novavax Inc
BPH
BPH Energy Limited
PFE
Pfizer Inc
NYR
Nyrada Inc.
SKN
Skin Elements Ltd
IMU
Imugene Limited
Related Articles
Loading...